Accuray Incorporated
CyberKnife System proven a viable solution for treatment of prostate cancer
Published in Surgery Litigation and Law Weekly, June 23rd, 2006
The study shows that the CyberKnife System is a minimally invasive procedure that can be performed on an outpatient basis with minimal or no side effects. The results of this study were presented by the Korea Institute of Radiological and Medical Sciences at the American Urological Association (AUA) 2006 Annual Meeting in Atlanta.
"With this study, we explored the advantages of robotic radiosurgery as a minimally...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals to acquire Quill Medical - SenoRx, Inc.
SenoRx announces settlement agreement with Suros Surgical in patent infringement case - Suros Surgical Systems, Inc.
Suros, SenoRx set terms to settle breast biopsy system patent infringement lawsuit - University of Pittsburgh
Researchers from University of Pittsburgh publish new studies and findings - Aachen University of Technology
Studies from Germany, Italy and India describe new findings in cardiology research - Advanced Medical Optics, Inc.
James V. Mazzo named board chair of Advanced Medical Optics, Inc. - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
